Introduction
Mitochondrial dysfunction has been linked to the pathogenic mechanisms of several neurodegenerative diseases (Schapira, 2006; Keating, 2008) . Neurons are particularly sensitive to alterations in normal mitochondrial function because of their high levels of activity and subsequent need for energy. 3-Nitropropionic acid (3-NP), an inhibitor of succinate dehydrogenase (Coles et al., 1979; Huang et al., 2006) , has been widely used to analyse the mechanisms by which metabolic impairment leads to the degeneration of neurons. In particular, 3-NP has been used in the context of Huntington's disease (HD), a hereditary neurodegenerative disease affecting the striatum and the cerebral cortex, since its administration in rodents and nonhuman primates causes abnormal movement, cognitive deficits and neuronal degeneration similar to that seen in HD patients (Beal et al., 1993; Brouillet et al., 1995; Blum et al., 2002) . In addition, postmortem brain extracts of HD patients showed reduced activity and expression levels of succinate dehydrogenase (Gu et al., 1996; Browne et al., 1997; Benchoua et al., 2006) . Although not entirely elucidated, the mechanisms of 3-NP-induced neurotoxicity involve depletion of ATP, mitochondrial membrane depolarization, dysregulation of intracellular calcium homeostasis, calpain activation, and release of proapoptotic proteins from mitochondria with the consequent activation of caspases and apoptotic pathways (Lee et al., 2002; Bizat et al., 2003; Almeida et al., 2004 Almeida et al., , 2006 . Although these changes may underlie massive striatal degeneration following 3-NP in vivo administration, a reduction in the activities of complexes I and II was also recently described in the cerebral cortex (Pandey et al., 2008) , implicating neuronal dysfunction in this brain area. Indeed, early cortical dysfunction, linked to striatal excitotoxicity and decreased trophic support, appears to have a fundamental role in the onset and progression of HD.
The mitochondrial death pathway is regulated by a fine balance between pro-apoptotic and pro-survival Bcl-2 family members (Cory and Adams, 2002) . Pro-apoptotic proteins such as Bax and Bak can disrupt the outer mitochondrial membrane and promote the release of apoptogenic factors such as cytochrome c or Smac/Diablo, an event that ultimately activates the caspase cascade. Apoptosis-inducing factor (AIF) can also be released from the mitochondria, leading to caspase-independent cell death (Susin et al., 1999) . In viable cells and under normal conditions, pro-apoptotic proteins are normally repressed by binding to pro-survival proteins such as Bcl-2 and Bcl-xL. In response to stress, BH3-only proteins, such as Bim, Bid, and Bad, bind to Bcl-2 or Bcl-xL, that then release Bax or Bak. These pro-apoptotic proteins then change their conformation and oligomerize in the mitochondrial membrane to promote cell death (Puthalakath and Strasser, 2002) .
Trophic support to neurons largely influences neuronal survival and function. Members of the neurotrophin family, namely brainderived neurotrophic factor (BDNF), have been suggested as therapeutic candidates to treat neurodegenerative disorders because they promote neuronal survival in different lesion models (e.g. Connor and Dragunow, 1998) . BDNF is particularly relevant in HD since its transcription (Zuccato et al., 2001 ) and axonal transport (Gauthier et al., Neurobiology of Disease 35 (2009) [448] [449] [450] [451] [452] [453] [454] [455] [456] 
